Polymeropoulos Mihael Hristos — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Polymeropoulos Mihael Hristos is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $42K. Lifetime open-market sales: $1.28M.
Profile
Mihael Hristos Polymeropoulos is the President and CEO of Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on developing therapies for unmet medical needs. He has been instrumental in leading the company through various stages of growth and product commercialization.
Role
Insider
Notability
50/100
Board memberships
Vanda Pharmaceuticals Inc.
Awards & honors
Led Vanda Pharmaceuticals as CEO
Oversaw the development of HETLIOZ
Contributed to the commercialization of multiple therapies
Mihael Hristos Polymeropoulos is the President and CEO of Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on developing therapies for unmet medical needs. He has been instrumental in leading the company through various stages of growth and product commercialization.…
Has Polymeropoulos Mihael Hristos been buying or selling stock?
Recorded transactions: 1 open-market purchases ($42K) and 1 open-market sales ($1.28M) across all tracked filings.
Where can I see all of Polymeropoulos Mihael Hristos's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
